Regulation of the membrane-localized prostaglandin E synthases mPGES-1 and mPGES-2 in cardiac myocytes and fibroblasts

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 288, Issue 1 57-1, 2005, Pages

  Giannico, Giovanna ^a   Mendez, Mariela ^a   LaPointe, Margot C ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Cyclooxygenase 2; Interleukin 1 ; Mitogen activated protein kinase; Prostaglandins

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CYCLOOXYGENASE 2; INTERLEUKIN 1BETA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROSTAGLANDIN E; PROSTAGLANDIN E SYNTHASE; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE MPGES 1; PROSTAGLANDIN SYNTHASE MPGES 2; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELLULAR DISTRIBUTION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DENSITOMETRY; ENZYME IMMUNOASSAY; ENZYME INHIBITION; ENZYME LOCALIZATION; FIBROBLAST; HEART DISEASE; HEART MUSCLE CELL; HEART VENTRICLE WALL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; CELL MEMBRANE; CELLS, CULTURED; CYCLOOXYGENASE 2; DINOPROSTONE; ENZYME INHIBITORS; FIBROBLASTS; INTERLEUKIN-1; MICROSCOPY, CONFOCAL; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCARDIUM; MYOCYTES, CARDIAC; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SUBCELLULAR FRACTIONS; TISSUE DISTRIBUTION;

EID: 11144271384     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00726.2004     Document Type: Article

References (53)

1. 2 production and alters the gastric prostanoid profile. J Biol Chem 279: 23229-23237, 2004.
2. Brook M, Sully G, Clark AR, and Saklatvala J. Regulation of tumour necrosis factor alpha mRNA stability by the mitogen-activated protein kinase p38 signalling cascade. FEBS Lett 483: 57-61, 2000.
3. Catley MC, Chivers JE, Cambridge LM, Holden N, Slater DM, Staples KJ, Bergmann MW, Loser P, Barnes PJ, and Newton R. IL-1beta-dependent activation of NF-kappaB mediates PGE2 release via the expression of cyclooxygenase-2 and microsomal prostaglandin E synthase. FEBS Lett 547: 75-79, 2003.
4. 2 synthase-1 expression in human synovial fibroblasts by interfering with Egr-1. J Biol Chem 279: 22057-22065, 2004.
5. Cipollone F, Fazia M, Iezzi A, Ciabattoni G, Pini B, Cuccurullo C, Ucchino S, Spigonardo F, De Luca M, Prontera C, Chiarelli F, Cuccurullo F, and Mezzetti A. Balance between PGD synthase and PGE synthase is a major determinant of atherosclerotic plaque instability in humans. Arterioscler Thromb Vasc Biol 24: 1259-1265, 2004.
6. Dean JL, Brook M, Clark AR, and Saklatvala J. p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes. J Biol Chem 274: 264-269, 1999.
7. Esnault S and Maker JS. Extracellular signal-regulated kinase mediates granulocyte-macrophage colony-stimulating factor messenger RNA stabilization in tumor necrosis factor-alpha plus fibronectin-activated peripheral blood eosinophils. Blood 99: 4048-4052, 2002.
8. Fanger GR, Gerwins P, Widmann C, Jarpe MB, and Johnson GL. MEKKs, GCKs, MLKs, PAKs, TAKs, and tpls: upstream regulators of the c-Jun amino-terminal kinases? Curr Opin Genet Dev 7: 67-74, 1997.
9. Forsberg L, Leeb L, Thoren S, Morgenstern R, and Jakobsson P. Human glutathione dependent prostaglandin E synthase: gene structure and regulation. FEBS Lett 471: 78-82, 2000.
10. Gallo KA and Johnson GL. Mixed-lineage kinase control of JNK and p38 MAPK pathways. Nat Rev Mol Cell Biol 3: 663-672, 2002.
11. Geng Y, Valbracht J, and Lotz M. Selective activation of the mitogen-activated protein kinase subgroups c-Jun NH2 terminal kinase and p38 by IL-1 and TNF in human articular chondrocytes. J Clin Invest 98: 2425-2430, 1996.
12. Guan Z, Buckman SY, Pentland AP, Templeton DJ, and Morrison AR. Induction of cyclooxygenase-2 by the activated MEKK1 → SEK1/MKK4 → p38 mitogen-activated protein kinase pathway. J Biol Chem 273: 12901-12908, 1998.
13. 2 synthase-1. J Biol Chem 279: 24866-24872. 2004.
14. 2 synthase expression. J Biol Chem 111: 16355-16364, 2002.
15. Herskowitz A, Choi S, Ansari AA, and Wesselingh S. Cytokine mRNA expression in postischemic/reperfused myocardium. Am J Pathol 146: 419-428, 1995.
16. Hwang D, Jang BC, Yu G, and Boudreau M. Expression of mitogen-inducible cyclooxygenase induced by lipopolysaccharide: mediation through both mitogen-activated protein kinase and NF-kappaB signaling pathways in macrophages. Biochem Pharmacol 54: 87-96, 1997.
17. Jakobsson PJ, Thoren S, Morgenstern R, and Samuelsson B. Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc Natl Acad Sci USA 96: 7220-7225, 1999.
18. Kamei D, Yamakawa K, Takegoshi Y, Mikami-Nakanishi M, Nakatani Y, Oh-Ishi S, Yasui H, Azuma Y, Hirasawa N, Ohuchi K, Kawaguchi H, Ishikawa Y, Ishii T, Uematsu S, Akira S, Murakami M, and Kudo I. Reduced pain hypersensitivity and inflammation in mice lacking microsomal prostaglandin E synthase-1. J Biol Chem 279: 33684-33695, 2004.
19. Kyriakis JM and Avruch J. Protein kinase cascades activated by stress and inflammatory cytokines. Bioessays 18: 567-577, 1996.
20. Kyriakis JM, Banerjee P, Nikolakaki E, Dai T, Rubie EA, Ahmad MF, Avruch J, and Woodgett JR. The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369: 156-160, 1994.
21. LaPointe MC and Isenovic E. Interleukin-1beta regulation of inducible nitric oxide synthase and cyclooxygenase-2 involves the p42/44 and p38 MAPK signaling pathways in cardiac myocytes. Hypertension 33: 276-282, 1999.
22. LaPointe MC, Mendez M, Leung A, Tao Z, and Yang XP. Inhibition of cyclooxygenase-2 improves cardiac function after myocardial infarction in the mouse. Am J Physiol Heart Circ Physiol 286: H1416-H1424, 2004.
23. LaPointe MC and Sitkins JR. Phorbol ester stimulates the synthesis and secretion of brain natriuretic peptide from neonatal rat ventricular cardiocytes: a comparison with the regulation of atrial natriuretic factor. Mol Endocrinol 1: 1284-1296, 1993.
24. LaPointe MC and Sitkins JR. Mechanisms of interleukin-1beta regulation of nitric oxide synthase in cardiac myocytes. Hypertension 27: 709-714, 1996.
25. Laporte JD, Moore PE, Panettieri RA, Moeller W, Heyder J, and Shore SA. Prostanoids mediate IL-1β-induced β-adrenergic hyporesponsiveness in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 275: L491-L501, 1998.
26. Lim CP, Jain N, and Cao X. Stress-induced immediate-early gene, egr-1, involves activation of p38/JNK1. Oncogene 16: 2915-2926, 1998.
27. 2 in cardiac myocytes. Hypertension 39: 382-388, 2002.
28. Morita I, Schindler M, Regier MK, Otto JC, Hori T, DeWitt DL, and Smith WL. Different intracellular locations for prostaglandin endoperoxide H synthase-1 and -2. J Biol Chem 270: 10902-10908, 1995.
29. 2 production by membrane-bound prostaglandin E synthase-2 via both cyclooxygenases-1 and -2. J Biol Chem 278: 37937-37947, 2003.
30. Murakami M, Nakatani Y, Tanioka T, and Kudo I. Prostaglandin E synthase. Prostaglandins Other Lipid Mediat 68-69: 383-399, 2002.
31. 2 synthase that acts in concert with cyclooxygenase-2. J Biol Chem 275: 32783-32792, 2000.
32. 2 synthase gene. Essential role of the transcription factor Egr-1. J Biol Chem 277: 28601-28608, 2002.
33. O'Neill LA and Greene C. Signal transduction pathways activated by the IL-1 receptor family: ancient signaling machinery in mammals, insects, and plants. J Leukoc Biol 63: 650-657, 1998.
34. Pyronnet S, Imataka H, Gingras AC, Fukunaga R, Hunter T, and Sonenberg N. Human eukaryotic translation initiation factor 4G (eIF4G) recruits mnk1 to phosphorylate eIF4E. EMBO J 18: 270-279, 1999.
35. Raingeaud J, Gupta S, Rogers JS, Dickens M, Han J, Ulevitch RJ, and Davis RJ. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 270: 7420-7426, 1995.
36. Ridley SH, Sarsfield SJ, Lee JC, Bigg HF, Cawston TE, Taylor DJ, DeWitt DL, and Saklatvala J. Actions of IL-1 are selectively controlled by p38 mitogen-activated protein kinase: regulation of prostaglandin H synthase-2, metalloproteinases, and IL-6 at different levels. J Immunol 158: 3165-3173, 1997.
37. Rolli M, Kotlyarov A, Sakamoto KM, Gaestel M, and Neininger A. Stress-induced stimulation of early growth response gene-1 by p38/stress-activated protein kinase 2 is mediated by a cAMP-responsive promoter element in a MAPKAP kinase 2-independent manner. J Biol Chem 274: 19559-19564, 1999.
38. Saito T, Rodger IW, Hu F, Shennib H, and Giaid A. Inhibition of cyclooxygenase-2 improves cardiac function in myocardial infarction. Biochem Biophys Res Commun 273: 772-775, 2000.
39. Schramek H. MAP kinases: from intracellular signals to physiology and disease. News Physiol Sci 17: 62-67, 2002.
40. Shioi T, Matsumori A, Kihara Y, Inoko M, Ono K, Iwanaga Y, Yamada T, Iwasaki A, Matsushima K, and Sasayama S. Increased expression of interleukin-1 beta and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in the hypertrophied and failing heart with pressure overload. Circ Res 81: 664-671, 1997.
41. Smith WL, DeWitt DL, and Garavito RM. Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 69: 145-182, 2000.
42. Spencer AG, Woods JW, Arakawa T, Singer H, and Smith WL. Subcellular localization of prostaglandin endoperoxide H synthases-1 and -2 by immunoelectron microscopy. J Biol Chem 273: 9886-9893, 1998.
43. Subbaramaiah K, Marmo TP, Dixon DA, and Dannenberg AJ. Regulation of cyclooxgenase-2 mRNA stability by taxanes: evidence for involvement of p38, MAPKAPK-2, and HuR. J Biol Chem 278: 37637-37647, 2003.
44. 2 biosynthesis. J Biol Chem 275: 32775-32782, 2000.
45. Trebino CE, Stock JL, Gibbons CP, Naiman BM, Wachtmann TS, Umland JP, Pandher K, Lapointe JM, Saha S, Roach ML, Carter D, Thomas NA, Durtschi BA, McNeish JD, Hambor JE, Jakobsson PJ, Carty TJ, Perez JR, and Audoly LP. Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase. Proc Natl Acad Sci USA 100: 9044-9049, 2003.
46. 2 synthase gene induced by the Toll-like receptor 4/MyD88/NF-IL6 pathway. J Immunol 168: 5811-5816, 2002.
47. Wang SW, Pawlowski J, Wathen ST, Kinney SD, Lichenstein HS, and Manthey CL. Cytokine mRNA decay is accelerated by an inhibitor of p38-mitogen-activated protein kinase. Inflamm Res 48: 533-538, 1999.
48. Wang X, Flynn A, Waskiewicz AJ, Webb BL, Vries RG, Baines IA, Cooper JA, and Proud CG. The phosphorylation of eukaryotic initiation factor eIF4E in response to phorbol esters, cell stresses, and cytokines is mediated by distinct MAP kinase pathways. J Biol Chem 273: 9373-9377, 1998.
49. Watanabe K, Kurihara K, and Suzuki T. Purification and characterization of membrane-bound prostaglandin E synthase from bovine heart. Biochim Biophys Acta 1439: 406-414, 1999.
50. Wilmer WA, Tan LC, Dickerson JA, Danne M, and Rovin BH. Interleukin-1beta induction of mitogen-activated protein kinases in human mesangial cells. Role of oxidation. J Biol Chem 111: 10877-10881; 1997.
51. Wong SC, Fukuchi M, Melnyk P, Rodger I, and Giaid A. Induction of cyclooxygenase-2 and activation of nuclear factor-kappaB in myocardium of patients with congestive heart failure. Circulation 98: 100-103, 1998.
52. Wuyts WA, Vanaudenaerde BM, Dupont LJ, Demedts MG, and Verleden GM. Involvement of p38 MAPK, JNK, p42/p44 ERK and NF-kappaB in IL-1 beta-induced chemokine release in human airway smooth muscle cells. Respir Med 97: 811-817, 2003.
53. Zhang S, Han J, Sells MA, Chernoff J, Knaus UG, Ulevitch RJ, and Bokoch GM. Rho family GTPases regulate p38 mitogen-activated protein kinase through the downstream mediator Pak1. J Biol Chem 270: 23934-23936, 1995.